Egis acquires Russian drug portfolio of Croatian peer
French-owned Hungarian drugmaker Egis on Monday announced its acquisition of the Russian skin care and womenʼs healthcare products portfolio of Croatian peer Jadran-Galenski Laboratorij (JGL), Hungarian news agency MTI reported today.
Egis targets a "big jump" in sales as a result of the acquisition.
Egisʼ exports to Russia came to HUF 31 billion in its 2015-2016 business year.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.